Literature DB >> 3095303

Successful treatment with ceftazidime of a Pseudomonas fluorescens chest infection in a myasthenic patient.

I Thangkhiew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3095303     DOI： 10.1093/jac/18.3.428

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections.

Authors:  Takeshi Nishimura; Kenji Hattori; Akihiko Inoue; Taiji Ishii; Tetsuya Yumoto; Kohei Tsukahara; Astunori Nakao; Satoshi Ishihara; Shinichi Nakayama
Journal:  World J Emerg Med       Date:  2017

Review 2.  Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans.

Authors:  Brittan S Scales; Robert P Dickson; John J LiPuma; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 3.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.